Pharmaceuticals
27 medicines sold by 18 pharma companies in India ‘fail’ quality tests

27 medicines sold by 18 pharma companies in India ‘fail’ quality tests

New Delhi: The drug regulators of seven states have alleged that 27 medicines sold by 18 major drug companies in India are of “substandard” quality. more

Experts call for fair vaccine pricing, not ‘random acts of charity’

Experts call for fair vaccine pricing, not ‘random acts of charity’

London: Drug companies should stop using donations to atone those who cannot afford expensive vaccines and instead lower prices, argue experts. more

Sanofi Pasteur introduces 6-in-1 paediatric vaccine Hexaxim

Sanofi Pasteur introduces 6-in-1 paediatric vaccine Hexaxim

New Delhi: Sanofi Pasteur on Thursday launched Hexaxim, a six-in-one vaccine indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age. more

No Indian pharma company features in world’s top 20 companies trying to make medicines affordable

No Indian pharma company features in world’s top 20 companies trying to make medicines affordable

New Delhi: Not even a single Indian pharmaceutical company features in the list of world’s top 20 companies that have attempted at making medicines affordable for those in low and middle income countries, revealed a recent study by the Netherlands-based Access to Medicine Foundation. more

ICMR researchers complete phase III clinical trials of a long-term use reversible male contraceptive

ICMR researchers complete phase III clinical trials of a long-term use reversible male contraceptive

New Delhi: Researchers at the Indian Council of Medical Research (ICMR) have completed the phase III clinical trials of Risug, a long-term use reversible male contraceptive, on 282 volunteers in five centres across India, and zero side-effects and difficulties have been reported, according to Dr R S Sharma, head of reproductive biology and maternal health at ICMR. more

Prices of 43 essential medicines reduced by up to 35%

Prices of 43 essential medicines reduced by up to 35%

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has reduced prices of 43 commonly used essential medicines by up to 35%. These drugs are used in treatment of ailments like diabetes, cancer, asthma, cardiovascular diseases, mental disorders and kidney failure. more

Govt considering to regulate prices of essential drugs only when required

Govt considering to regulate prices of essential drugs only when required

New Delhi: The government is reportedly considering to disband the National Pharmaceutical Pricing Authority (NPPA) and assume the power to set prices of essential medicines, as it seeks to address concerns that excessive controls were stifling innovation and competitiveness of the sector. more

US FDA approves new treatment for advanced soft tissue sarcoma

US FDA approves new treatment for advanced soft tissue sarcoma

Washington: The US Food and Drug Administration has granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. more

Teva, Celltrion join hands to commercialize biosimilars in US, Canada

Teva, Celltrion join hands to commercialize biosimilars in US, Canada

Jerusalem: Teva Pharmaceutical Industries, Celltrion and Celltrion Healthcare on Thursday announced that the companies have entered into an exclusive partnership to commercialize CT-P10 and CT-P6 — two of Celltrion’s mAb (monoclonal antibody) biosimilar candidates — in the US and Canada. more

Kaposi’s sarcoma drug DaunoXome to be available in India under Named Patient Programme

Kaposi’s sarcoma drug DaunoXome to be available in India under Named Patient Programme

Bangalore: Sayre Therapeutics on Monday announced the establishment of a Named Patient Programme for DaunoXome (liposomal daunorubicin) for India, Sri Lanka, Bangladesh, Nepal and Pakistan, under an exclusive distribution arrangement with Galen. more